| Dr Shari Gayle Maletsky-smith, MD | |
|
3300 Gallows Road, Department Of Medicine, Falls Church, VA 22042-3307 | |
| (703) 776-3582 | |
| Not Available |
| Full Name | Dr Shari Gayle Maletsky-smith |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Location | 3300 Gallows Road, Falls Church, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174790034 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 0101247147 (Virginia) | Secondary |
| 207R00000X | Internal Medicine | 0101247147 (Virginia) | Primary |
| Entity Name | Inova Health Care Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952320061 PECOS PAC ID: 2466351093 Enrollment ID: O20040102000644 |
News Archive
meridianEMR, Inc., a leading provider of electronic health records systems and advanced healthcare analytics for urology and surgical practices, today has announced the launch of its exclusive multi-dimensional clinical analysis tool – UROAnalytics.
At the College of American Pathologists annual meeting this month, more than 1,300 pathologists will collaborate on the promise, challenges, and questions surrounding immunotherapy—the subject of the opening Scientific Plenary at CAP16 - The Pathologists' Meeting in Las Vegas on Sept. 25.
St. Luke's Cancer Center is a leader in offering clinical trials for patients with melanoma, the most unusual type of skin cancer and also the most deadly. Physicians such as Sanjiv Agarwala, MD, Chief of Medical Oncology and Hematology for St. Luke's University Health Network and an internationally recognized melanoma specialist, are committed to bringing the most promising studies to the Lehigh Valley.
Cardiologists at Washington University School of Medicine in St. Louis have developed a noninvasive imaging technique that may help determine whether children who have had heart transplants are showing early signs of rejection. The technique could reduce the need for these patients to undergo invasive imaging tests every one to two years.
Omeros Corporation today announced initiation of enrollment in a Phase 2 clinical trial of OMS824, the company's phosphodiesterase 10 inhibitor. The trial will evaluate the compound's tolerability, safety, pharmacokinetics, potential interactions with concomitant antipsychotic medications, and a battery of cognitive tests in patients with stable schizophrenia.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Shari Gayle Maletsky-smith, MD Po Box 37174, Baltimore, MD 21297-3174 Ph: (571) 423-5699 | Dr Shari Gayle Maletsky-smith, MD 3300 Gallows Road, Department Of Medicine, Falls Church, VA 22042-3307 Ph: (703) 776-3582 |
News Archive
meridianEMR, Inc., a leading provider of electronic health records systems and advanced healthcare analytics for urology and surgical practices, today has announced the launch of its exclusive multi-dimensional clinical analysis tool – UROAnalytics.
At the College of American Pathologists annual meeting this month, more than 1,300 pathologists will collaborate on the promise, challenges, and questions surrounding immunotherapy—the subject of the opening Scientific Plenary at CAP16 - The Pathologists' Meeting in Las Vegas on Sept. 25.
St. Luke's Cancer Center is a leader in offering clinical trials for patients with melanoma, the most unusual type of skin cancer and also the most deadly. Physicians such as Sanjiv Agarwala, MD, Chief of Medical Oncology and Hematology for St. Luke's University Health Network and an internationally recognized melanoma specialist, are committed to bringing the most promising studies to the Lehigh Valley.
Cardiologists at Washington University School of Medicine in St. Louis have developed a noninvasive imaging technique that may help determine whether children who have had heart transplants are showing early signs of rejection. The technique could reduce the need for these patients to undergo invasive imaging tests every one to two years.
Omeros Corporation today announced initiation of enrollment in a Phase 2 clinical trial of OMS824, the company's phosphodiesterase 10 inhibitor. The trial will evaluate the compound's tolerability, safety, pharmacokinetics, potential interactions with concomitant antipsychotic medications, and a battery of cognitive tests in patients with stable schizophrenia.
› Verified 5 days ago
Amita Rajani, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 3300 Gallows Road Inova Fairfax Medical Campus, Department Of Medicine, Npt-2, Falls Church, VA 22042 Phone: 703-776-7780 | |
Dr. Mary Beck O'donnell, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 2960 Sleepy Hollow Rd, Falls Church, VA 22044 Phone: 703-536-2000 Fax: 703-536-4256 | |
Lindsey A. Cilia, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2901 Telestar Ct Ste 200, Falls Church, VA 22042 Phone: 703-573-3494 Fax: 703-573-5353 | |
Chin Hee Kim, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd Dept Of, Falls Church, VA 22042 Phone: 703-776-3582 | |
Candyce Heather Greene, MD, MPH, MSW Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-4001 Fax: 703-776-7113 | |
Dr. Megan Elizabeth Terek, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-4001 Fax: 703-776-7113 | |
Dr. Hazim El-haddad, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2901 Telestar Ct Ste 200, Falls Church, VA 22042 Phone: 703-573-3494 Fax: 703-573-5353 |